G1 THERAPEUTICS, INC. Proceeds from Stock Options Exercised
G1 THERAPEUTICS, INC. reported Proceeds from Stock Options Exercised of $258.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-08-08
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2024-06-30 was $232.00K.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2024-03-31 was $26.00K, a 2500.00% increase year-over-year.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2023-12-31 was $33.00K, a 230.00% increase year-over-year.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2023-09-30 was $23.00K, a 81.89% decline year-over-year.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2023 was $57.00K, a 63.23% decline from fiscal 2022.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2022 was $155.00K, a 97.35% decline from fiscal 2021.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2021 was $5.84M, a 153.25% increase from fiscal 2020.
- G1 THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2020 was $2.31M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $258.00K 10-Q · filed 2024-08-08 | $291.00K derived: sum of 3 quarters · filed 2024-08-08 | $314.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $26.00K 10-Q · filed 2024-05-01 | $59.00K derived: sum of 2 quarters · filed 2024-05-01 | $82.00K derived: sum of 3 quarters · filed 2024-05-01 | $82.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $56.00K derived: sum of 2 quarters · filed 2024-02-28 | $56.00K derived: sum of 3 quarters · filed 2024-08-08 | $57.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $23.00K derived: sum of 2 quarters · filed 2024-08-08 | $24.00K 10-Q · filed 2023-11-01 | $34.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.00K 10-Q · filed 2024-08-08 | $11.00K derived: sum of 3 quarters · filed 2024-08-08 | $138.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-01 | $11.00K derived: sum of 2 quarters · filed 2024-05-01 | $138.00K derived: sum of 3 quarters · filed 2024-05-01 | $138.00K derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $137.00K derived: sum of 2 quarters · filed 2024-02-28 | $137.00K derived: sum of 3 quarters · filed 2024-02-28 | $155.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $127.00K derived: sum of 2 quarters · filed 2023-11-01 | $145.00K 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $18.00K 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $18.00K 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $5.84M 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $2.31M 10-K · filed 2023-03-01 |